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Isopentenyl diphosphate (IPP) isomerase catalyzes an 
essential activation step in the isoprene biosynthetic 
pathway. The Saccharomyces cerevisiae gene for IPP 
isomerase, IDI1, was recently isolated and character­
ized (Anderson, M. S., Muehlbacher, M., Street, I. P., 
Proffitt, J., and Poulter, C. D. (1989) J. Biol. Chem. 264, 
19169-19175), and the wild-type gene, ID/1, was dis­
rupted  with a LEU2 m arker to create a diploid yeast 
strain  heterozygous for the idil::leu2 disruption, which 
revealed that IDI1 was an essential single-copy gene 
(Mayer, M. P., Hahn, F. M., Stillman, D. J., and Poulter,
C. D. (1992) Yeast 8, 743-748). We now report the isola­
tion of a cDNA clone from Schizosaccharomyces pombe 
by a plasmid shuffle-mediated complementation of the 
LEU2 disrupted yeast gene. The S. pombe clone encoded 
a 26,864-dalton polypeptide of 227 amino acids with a 
high degree of sim ilarity to the S. cerevisiae IDI1 en­
zyme. S. pombe IPP isomerase contained the essential 
Cys and Glu catalytic residues identified in yeast 
isomerase (Street, I. P., Coffman, H. R., Baker, J., and 
Poulter, C. (1994) Biochemistry 33, 4212-4217) but was 
significantly smaller than  the S. cerevisiae enzyme. The 
plasmid shuffle technique is an excellent procedure for 
screening expression libraries for IPP isomerase activ­
ity by complementation of the id il  mutation.
The isoprenoid biosynthetic pathway, with more than  23,000 
known metabolites, is the most diverse found in nature. The 
pathway is found in all organisms (1) and produces several 
im portant classes of compounds, including sterols (2), carote­
noids (3), dolichols (4), ubiquinones (5), and prenylated proteins 
(6). All of these compounds are derived from linear isoprenoid 
diphosphates synthesized from the isomeric five-carbon in ter­
mediates isopentenyl diphosphate (IPP)1 and dimethylallyl 
diphosphate (DMAPP) (7). In eukarya and archae where the 
pathway is well established, IPP is synthesized from three 
molecules of acetyl-CoA by the mevalonate pathway (8). How­
ever, in some bacteria IPP appears to be synthesized from an as 
yet unidentified three-carbon precursor by a new non-meval-
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onate route (9). Beyond IPP, the pathway for constructing 
polyisoprenoid chains is sim ilar for organisms in all three m a­
jor kingdoms.
Isopentenyl diphosphate:dimethylallyl diphosphate isomer­
ase (IPP isomerase; EC 5.3.3.2) catalyzes a crucial activation 
step in the isoprenoid pathway by converting IPP to its highly 
electrophilic isomer DMAPP. These two intermediates are the 
initial substrates for prenyltransferases th a t synthesize poly­
isoprenoid chains. The antarafacial isomerization of IPP to 
DMAPP illustrated in Scheme 1 (7) occurs by a protonation- 
deprotonation mechanism (10-13).
/D /1, the gene for IPP isomerase in Saccharomyces cerevi­
siae, was recently isolated (14) and characterized as a single­
copy gene on chromosome XVI (15). Recombinant yeast enzyme 
was purified to homogeneity, and two essential catalytic site 
residues, Cys139 and Glu207, were identified by a combination of 
affinity labeling and site-directed mutagenesis experiments 
(16-18). Recently, Xuan et al. (19) reported a hum an cDNA 
clone with an open reading frame (orf) th a t encoded a protein 
with a high degree of similarity to yeast IPP isomerase, includ­
ing the essential Cys and Glu residues. However, the putative 
hum an enzyme had a 52-amino acid deletion a t its amino 
term inus, and catalytic activity was not established. We were 
interested in developing a procedure th a t would allow us to 
screen heterologous libraries for genes encoding IPP isomerase 
by complementation in order to obtain sequence information 
and protein for comparative studies. We previously described 
construction of S. cerevisiae strain  FH2-5b (15) and now report 
its use to isolate a cDNA clone for IPP isomerase from Sch iz­
osaccharomyces pom be  by a plasmid shuffle technique and 
synthesis of the S. pom be  enzyme in Escherichia coli.
EXPERIM ENTAL PROCEDURES
Materials—[1-14C]IPP was purchased from Amersham Corp. DE52 
ion exchange resin was from W hatman, and phenyl-Sepharose was 
purchased from Pharm acia Biotech Inc. DL-rt-Ami noadipic acid (a-AA), 
adenine, uracil, L-leucine, L-lysine, L-tryptophan, and L-histidine were 
from Sigma. SeaKem ME agarose was from FMC BioProducts. All 
restriction endonucleases were purchased from New England Biolabs, 
and T4 DNA ligase was from Boehringer Mannheim. pBluescript II 
SK( + ) was from Stratagene. pARC306N was provided by M. Bittner 
(Biotechnology Division, Amoco Research, Naperville, IL). pIPS139 was 
available from a previous study (18). pYES2.0 was from Invitrogen. 
Oligonucleotide primers and linkers were synthesized by Bob Schack- 
mann, U tah Regional Cancer Center, Protein/DNA Core Facility.
Strains, Media, and Growth Conditions—The haploid S. cerevisiae 
strain FH2-5b (MATa, acfe2-101, ft/s3-A200, Ieu2-Al, /_ys2-801, trpl- 
A63, ura3-52, idi\v.LEU'l, pRS317:7/5/1) was described by Mayer et al.
(15). A S. pombe cDNA expression library was obtained from L. Guar- 
ente, H arvard University (20). E. coli strains DH5a (F , 
<J>80d/acZAM15, endAl, recAl, h sdR ll (r- k, m - k), supE44, thi-1, 
gyrA96, relAl; Life Technologies, Inc.) and JM101 (A(lac-proAB), supE, 
th i lF ', fraD36. proAB, ZacIqZAM15 (21) were used for cloning proce­
dures. S. cerevisiae strains were grown at 30 °C in YEPD medium (22) 




















supplements as required by auxotrophies: adenine (0.06 g/liter), uracil 
(0.06 g/literl. leucine (0.1 g/liter», lysine (0.08 g/literl. tryptophan (0.08 
g/liter), and histidine (0.02 g/liter). Medium containing a-AA is de­
scribed by Sikorski and Boeke (24). Transformed E .  c o l i  strains were 
grown at 37 °C in LB broth containing 5 g of Difco yeast extract, 10 g of 
Difco tryptone. 10 g of NaCl, and 75 mg of ampicillin in 1 liter of H.,0 
or M9/CAGM medium containing M9 salts (25), casamino acids (1 9} 
w/v), glucose (0.269; w/v). MgSO, (0.3 g/liter), CaCl2 (0.004 g/liter), 
thiamine hydrochloride (0.025 g/liter), FeCl2 (0.0054 g/literl, and ampi­
cillin (75 mg/liter). Radioactivity was measured in Optifluor scintilla­
tion fluid (Packard Instrument Co.) using a Packard Tri-Carb model 
4530 liquid scintillation spectrometer.
G e n e r a l  M e t h o d s —Minipreparations of plasmid DNA for restriction 
analysis were obtained by the boiling method as described by Sambrook 
e t  a l .  (25). Large scale plasmid preparations (>100 jxg) were performed 
using a purification kit from Qiagen. DNA fragments were purified 
using a GeneClean k it from BiolOl. Restriction digests, ligations, and 
E .  c o l i  transformations were conducted as described by Sambrook e t  a l .  
(25). Plasmids were isolated from yeast as described by Robzyk and 
Kassir (26i. IPP isomerase was assayed by the acid lability procedure 
(27). Ion exchange and hydrophobic interaction chromatographies were 
conducted at 4 °C using a Pharmacia FPLC system. SDS-polyacryl- 
amide gel electrophoresis was performed using the discontinuous buffer 
system of Laemmli (28). and the gels were stained with Coomassie 
Brilliant Blue R (Sigma). Protein concentrations were determined by 
the method of Bradford (29) using bovine serum albumin as standard.
T r a n s f o r m a t i o n  o f  S .  c e r e v i s i a e  S t r a i n  F H 2 - 5 b —S .  c e r e v i s i a e  strain 
FH2-5b was grown in YEPD medium to OD(ion 0.75 and transformed 
with 10 n g of DNA from the S. p o m b e  library by the modified lithium 
acetate procedure of Elbe (30). Transformants were plated on ura , 
leu , lys media (synthetic minimal media plus adenine, histidine, and 
tryptophan) and selected for prototrophy on media lacking the supple­
ment corresponding to the selectable marker on the plasmid used for 
the transformation.
a-AA S e l e c t i o n  / C o u n t e r s e l e c t i o n —Plates containing S .  c e r e v i s i a e  
transformed with the S. p o m b e  cDNA library were washed with 5 ml of 
medium containing a-AA (24). The colonies were removed from the 
surface by gentle swirling, transferred to sterile 50-ml centrifuge tubes, 
and spun for 10 min at 3,000 rpm. The supematants were decanted, and 
the pellets were resuspended in 1 ml of a-AA medium. The entire 
suspension was transferred to a-AA plates 1100 fxl/plate) and incubated 
at 30 ° C .
P l a s m i d  I s o l a t i o n  f r o m  a-AA S e l e c t e d  Y e a s t  C o l o n i e s —Cultures (3 
ml) containing a-AA (2 mg/ml) were prepared by inoculation with indi­
vidual S. c e r e v i s i a e  colonies that survived a-AA selection and incubated 
at 30 ° C  until turbid. Plasmid DNA was isolated and used to transform 
E .  c o l i  DH5a. Single colonies resulting from the transformation reac­
tions were used to inoculate 3 ml of LB/ampicillin, and the cultures
HB*





Scheme 1. Interconversion o f IPP and DMAPP.
were grown overnight at 37 C.
C o m p l e m e n t a t i o n  o f  D i s r u p t e d  1 1 ) 1 1 —The heterozygous diploid yeast 
strain FH1 (DY833 i d i \ : : l e u 2 )  was transformed, as described in Mayer 
e t  a l .  (15). Transformants were used to inoculate sporulation media (23, 
35) and grown at 30 C for 5 days. The asci were dissected (23, 35) on a 
YEPD plate. Following incubation at 30 °C. spores that were both uracil 
and leucine prototrophs were identified by replica plating. Mating type 
determinations (31) were used to identify haploid spores as follows. A 
master plate corresponding to the dissected asci was created by streak­
ing separated spores on a YEPD plate. Each horizontal row of streaks 
corresponded to a dissected ascus. Following overnight incubation at 
30 C, the master plate was replica plated to synthetic minimal me­
dium. Each streak on the synthetic minimal plate was cross-streaked 
with both mating type a and mating type a strains, and the plate was 
incubated overnight at 30 C. A patch of growth at cross-streaked 
intersections indicated a positive mating reaction.
C l o n i n g  t h e  S .  p o m b e  I P P  I s o m e r a s e  G e n e — H i n d  111 digests were 
performed on four plasmids identified as containing DNA able to com­
plement disrupted S .  c e r e v i s i a e  1 1 ) 1 1 The 1-kb hands were excised from 
0.89} agarose gels, purified by GeneClean. and ligated into the //m d lll 
site of pBluescript II SK< +).
S e q u e n c i n g  M e t h o d s —DNA sequence analysis was performed by the 
dideoxy chain termination method of Sanger e l  a l .  (32) with a Seque- 
nase 2.0 k it (U. S. Biochemical Corp.). Using primers corresponding to 
the T3 and T7 promoters of pBluescript. the four cDNA inserts were 
partially sequenced and determined to be identical. The insert in 
pBSF19 was sequenced in both directions. Computer-assisted analysis 
of sequence data was performed using MacGel 1.0, DNA Strider and 
Translate.
E x p r e s s i o n  a n d  P u r i f i c a t i o n  o f  S .  P o m b e  I P P  I s o m e r a s e —Unique 
N d e  I and S a l  I restriction endonuclease sites were introduced into the S .  
p o m b e  IPP isomerase gene in pBSF19 by Kunkel mutagenesis (33) 
using the Muta-Gene Phagemid i n  v i t r o  Mutagenesis K it version 2 
(Bio-Radi and primers 5 '-CAGTGTGCTCTAt'ATATGAGTTCCCAA- 
CAA-3' and 5 -CGTTGCTAAAGTCGACAAATTTTACCAGAG-3\ Start 
and stop codons are in bold, and the new restriction sites are under­
lined. A N d e V S a l l  double digest of the mutants gave a 0.7-kb DNA 
fragment containing S. p o m b e  /D/1. The DNA was electrophoresed on a 
0.89} agarose gel. excised, purified by GeneClean, and ligated into the 
N d e l  and S a l  I sites of the E .  c o l i  expression vector pARC306N.
The resulting plasmid, pFMH6, was used to transform E .  c o l i  JM 101 
competent cells. LB/ampicillin cultures (3 ml) were inoculated with 
single colonies and grown overnight at 37 °C. The 3-ml cultures were 
then used to inoculate 330 ml of M9/CAGM. The cultures were incu­
bated at 37 °C until the ODlio<, was 0.6-0.9. Nalidixic acid (15 mgi was 
added, and incubation was continued for 3 h. Cells were harvested by 
centrifugation at 10.000 x g  for 10 min and frozen at 80 C in 1-g 
portions.
Two grams of cell paste were suspended in 10 ml of 10 mM potassium 
phosphate, 10 mM 0-mercaptoethanol (BME), 1 m.M phenylmethylsul- 
fonyl fluoride, pH 7.0, and disrupted by sonication. The resulting ho- 
mogenate was centrifuged at 4 °C to remove cellular debris. The super­
natant was then loaded at 4 °C on a 1.5 x 30-cm DE52-cellulose column 
previously equilibrated with 10 mM potassium phosphate. 10 m.M BME. 
pH 7.0 (buffer A). The column was eluted at 1.5 ml/min with a 150-ml 
linear gradient of buffer A to 1009} buffer B (500 m.M potassium phos­
phate, 10 mM BME, pH 7.0). Active fractions were collected and com-
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Fig. 1. Restriction analysis o f 
pDB20, S. p o m b e  cDNA lib ra ry  and 
plnsmids isolated from  a single a-AA- 
selected yeast colony. P a n e l  A: l a n e s  1 
and 4 ,  DNA markers; l a n e  2 ,  B g l I digest 
of pDB20; l a n e  3 ,  B g l I digest of S .  p o m b e  . .
cDNA library. P a n e l  B :  l a n e s  I  and 1 2 ,  3 ^
DNA markers; l a n e  2 .  B g l  I digest of 
pDB20; l a n e s  3 - 1 1 ,  B g l  I digests of iso- 2 kb






















Fig. 2. Gene and pro te in  sequences 
fo r S. p o m b e  IPP isomerase. DNA from 
the host vector pDB20 is in bold. Start 
and stop codons are in italics.
9 7  k D a  
6 6  k O a
4 5  k D a
3 1  k D a
2 2  k D a  
1 4  k D a
Fig. 3. SDS-polyacrylamide gel o f steps in  the pu rifica tion  o f 
recom binant S. p o m b e  IPP isomerase. Lane A, molecular mass 
standards; lane B, cell-free extract; lane C, after chromatography on 
DE52; lane D, combined “early” fractions after chromatography on 
phenyl-Sepharose; lane E, combined “late" fractions after chromatogra­
phy on phenyl-Sepharose.
bined. (NH4)2S04 (1.5 M), 100 mM potassium phosphate, 10 mM BME, 
pH 7.0, was added to the combined fractions, while stirring on ice, until 
a final concentration of 1.2 M (NH4)2S04 was reached. The solution was 
then loaded at 4 °C onto a 1.5 x 30-cm phenyl-Sepharose column 
preequilibrated with 1.2 M (NH4)2S04, 100 mM  potassium phosphate, 10 
m M  BME, pH 7.0 (buffer C). Purification was achieved by running a 
100-ml linear gradient to 100% buffer D containing 100 m.M potassium 
phosphate, 10 m.M BME, pH 7.0.
Truncation of S. cerevisiae IPP Isomerase—S. cerevisiae IDI1 was 
isolated from a NdeVAatll double digestion of pIPS139 (18) by electro­
phoresis on a 0.8% agarose gel. The 3.65-kb DNA fragment was excised, 
purified by GeneClean, and recircularized with a synthetic double­
stranded oligonucleotide, containing the necessary complementary
CCGGCCGCCAGTGTGCTCTAAAGATGAGTTCCCAACAAGAGAAAAAGGATTATGATGAAG 60
M S S Q Q E K K D Y D E  12
AACAATTAAGGTTGATGGAAGAAGTTTGTATCGTTGTAGATGAAAATGATGTCCCTTTAA 120 
E Q L R L M E E V C I V V D E N D V P L  32
GATATGGAACGAAAAAGGAGTGTCATTTGATGGAAAATATAAATAAAGGTCTTTTGCATA 180 
R Y G T K K E C H L M E N I N K G L L H  52
GAGCATTCTCTATGTTCATCTTTGATGAGCAAAATCGCCTTTTACTTCAGCAGCGTGCAG 240 
R A F S M F I F D E Q N R L L L Q Q R A  72
AAGAGAAAATTACATTTCCATCCTTATGGACGAATACATGTTGCTCCCACCCATTGGATG 300 
E E K I T F P S L W T N T C C S H P L D  92
TTGCTGGTGAACGTGGTAATACTTTACCTGAAGCTGTTGAAGGTGTTAAGAATGCAGCTC 360 
V A G E R G N T L P E A V E G V K N A A  112
AACGCAAGCTGTTCCATGAATTGGGTATTCAAGCCAAGTATATTCCCAAAGACAAATTTC 420 
Q R K L F H E L G I Q A K Y I P K D K F  132
AGTTTCTTACACGAATCCATTACCTTGCTCCTAGTACTGGTGCTTGGGGAGAGCATGAAA 480 
Q F L T R I H Y L A P S T G A W G E H E  152
TTGACTACATTCTTTTCTTCAAAGGTAAAGTTGAGCTGGATATCAATCCCAATGAAGTTC 540 
I D Y X L F F K G K V E L D I N P N E V  172
AAGCCTATAAGTATGTTACTATGGAAGAGTTAAAAGAGATGTTTTCCGATCCTCAATATG 600 
Q A Y K Y V T M E E L K E M F S D P Q Y  192
GATTCACACCATGGTTCAAACTTATTTGTGAGCATTTTATGTTTAAATGGTGGCAGGATG 660 
G F T P W F K L I C E H F M F K W W Q D  212
TAGATCATGCGTCAAAATTCCAAGATACCTTAATTCATCGTTGCTAAAGTCTTTAAATAT 720 





ends to give pIPS139T. Digestion of the plasmid with ficoRI and Xhol 
gave a DNA fragment containing yeast /D/1 lacking the 5' sequence 
encoding 45 amino-terminal amino acids. The 0.7-kb DNA fragment 
was subcloned into the ScoRI and Xhol sites of the yeast expression 
vector pYES2.0 to give pFMHlO.
RESULTS
a-AA Selection I Counterselection o f S. cerevisiae FH2-5b 
Transformants—The S. pombe library used in these experi­
ments was constructed by cloning poly(dT)-primed cDNA into 
^  the unique B stX l site of pDB20, a yeast-£. coli shuttle vector
with a URA3 selectable marker and a yeast A D H l promoter 
(20). More than 40,000 colonies were obtained upon transfor­
mation of yeast strain FH2-5b and selection for uracil, leucine, 
and lysine prototrophy. The transformants were subjected to 
selection/counterselection as described by Sikorski and Boeke 
(24). Haploid strain FH2-5b had a disrupted chromosomal copy 
of ID I1 which was complemented by an episomal copy of the 
wild-type gene on pFMHl (15). pFMHl also contained LYS2  
and the LYS2  gene product produced a toxic semialdehyde 
when FH2-5b was grown on medium containing a-AA (34). 
These conditions selected against cells that did not lose 
pFMHl. Thus, double transformants of FH2-5b containing 
pFMHl and a plasmid from the cDNA library lost pFMHl upon 
treatment with a-AA (24). However, since IDI 1 is an essential 
single-copy gene in yeast, the loss of pFMHl was lethal unless 
the id i 1 mutation was complemented by a functional isomerase 
gene in the cDNA library. Of the >40,000 colonies transformed 
with S. pombe cDNA, only 23 survived counterselection with 
a-AA (24).
Plasmid DNA from a random selection of 11 of the 23 survi­
vors was used to transform E. coli strain DH5a. Restriction 
analysis of B gll fragments from E. coli plasmid DNA transfor­
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Scheme 2. Construction of yeast ex­
pression vector pFMHIO containing 
the truncated S. cerevisiae IPP 
isomerase gene (IDI1T).
EcoRI/Xhol





gave bands a t 1.5, 2.0, and 3.7 kb. In contrast, DNA from the 
library gave distinct bands a t 1.5 and 3.7 kb, but the band a t 
2.0 kb was replaced by a sm ear between 2.0 and 3.5 kb. Four of 
the 11 survivors selected for further study contained plasmids 
th a t gave identical B g ll restriction patterns with bands at 1.5, 
3.0, and 3.7 kb. Plasmids from four of the survivors th a t did not 
give bands a t 1.5 and 3.7 kb were subsequently treated with 
SalJJNcol and found to give a band a t 0.5 kb corresponding to 
N col and S ail restriction sites in wild-type IDI1.
Complementation o f  D isrupted  ID I1—The diploid yeast 
strain  FH1 (15), heterozygous for the idiV.deu2 disruption, was 
transformed with each of the four positive plasmids identified 
by restriction analysis, each corresponding to a different sur­
vivor of a-AA counterselection. Sporulation and dissection of 
the four transform ants gave viable spores th a t were u ra  ‘ and 
leu+, indicating th a t the U RA3 m arker of the pDB20-derived 
plasmid had segregated w ith the LE U 2  m arker of the gene 
disruption. Mating type analysis showed th a t the uracil and 
leucine prototrophs were haploid. Thus, all four plasmids con­
tained DNA th a t was able to complement the disrupted IPP 
isomerase gene.
Characterization o f  S. pombe IDI1 cDNA—S. pombe cDNA was 
removed from the four positive clones by restriction with Hin&Ill 
and ligated into pBluescript II SK(+). Partial DNA sequencing
experiments indicated tha t all four inserts were identical. A 
single plasmid was selected and sequenced. An orf beginning 
with a methionine codon was found 8 base pairs downstream 
from the B stX l cDNA insertion site. The nucleotide sequence of 
the S. pombe IPP isomerase orf and flanking DNA is shown in 
Fig. 2. The orf encodes a protein of 227 amino acids with a 
predicted mass of 26,864 daltons. Although the S. pombe protein 
has a high degree of similarity to S. cerevisiae IPP isomerase, the 
smaller S. pom be enzyme lacks 52 amino acids found a t the 
amino terminus of S. cerevisiae IPP isomerase.
Expression o f  S. pom be IDI1 and  P urification o f  IP P  Isom er­
ase—Kunkel mutagenesis was used to introduce a N d el site at 
the s ta rt codon and a S a il site ju s t downstream from the stop 
codon of the S. pom be  orf. The 0.7-kb N d e l/S a il fragment was 
cloned into pARC306N as described for the S. cerevisiae gene 
(18). The resulting plasmid, pFMH6, was used to transform E. 
coli strain  JM101. Cultures of JM101/pFMH6 in M9/CAGM 
medium were grown at 37 °C, and plasmid-directed protein 
synthesis was induced by the addition of nalidixic acid. S. 
pom be  IPP isomerase was purified from cell-free crude extracts 
in two steps by ion exchange chromatography on DE52-cellu- 
lose and by hydrophobic interaction chromatography on phenyl- 
Sepharose as described for yeast protein (18). This procedure 



















SDS-polyacrylamide gel electrophoresis (see Fig. 3). The spe­
cific activity of the pure S. pombe IPP isomerase (20 units/mg) 
is similar to that of the S. cerevisiae enzyme (18).
Truncation o f S. cerevisiae IPP Isomerase and Functional 
Complementation o f D isrupted IDI1—Deletion of the 45 amino- 
terminal amino acids in S. cerevisiae IPP isomerase was ac­
complished by removal of the 143-base pair fragment between 
the N deI site in the start codon and the downstream Aafll site 
to give a protein of similar size to the S. pombe IPP isomerase 
and the putative human enzyme. As outlined in Scheme 2, 
pIPS139 (18) was restricted with Aa/II and N de I. The 3.65-kb 
band was purified by agarose gel electrophoresis and ligated 
with a synthetic linker to close the incompatible ends and 
maintain the proper reading frame. The region corresponding 
to the orf for IPP isomerase in the truncated plasmid pIPS139T 
was sequenced.
The truncated S. cerevisiae IDI 1 gene was expressed in E. 
coli. The 0.8-kb N deVSall fragment from pIPS139T was ligated 
into pARC306N to create pFMH5. E. coli JM101/pFMH5 trans­
formants were used to inoculate M9/CAGM cultures grown at 
37 °C. Cell-free crude extracts from JM101/pFMH5 had 5-fold 
increased levels of isomerase activity above those from JM101 
controls containing pARC306N without the insert (28). Analy­
sis of low speed supernatants and pellets of cell-free extracts 
from E. coli JM101/pFMH5 by SDS-polyacrylamide gel electro­
phoresis indicated that a substantial portion of the truncated 
protein segregated with the pellet.
Rather than optimizing expression in E. coli, we decided to 
determine if the truncated yeast gene would complement dis­
rupted IDI 1 to give a viable S. cerevisiae strain. The truncated 
orf for yeast IPP isomerase was removed from pIPS139T as a 
0.7-kb fragment by digestion with £coRI/X/ioI and cloned into 
the yeast expression vector pYES2.0 to produce pFMHlO. Dip­
loid S. cerevisiae strain FH1, an idil::leu2  heterozygote, was 
transformed to uracil prototrophy. Sporulation medium (23,35) 
w'as inoculated with isolated transformants and incubated at 
30 °C for 5 days. The resulting asci were dissected on a YEPD 
plate and incubated at 30 °C. Haploid spores able to grow 
without uracil and leucine were identified by replica plating as 
shown in Fig. 4. Thus, the truncated form of S. cerevisiae IPP 
isomerase, although unstable, had sufficient activity to comple­
ment disrupted IDI 1.
DISCUSSION
The conversion of IPP to DMAPP catalyzed by IPP isomerase 
is an essential step in the biosynthesis of all isoprenoids. Al­
though impure preparations of the enzyme have been studied 
from a wide variety of organisms, the only proteins purified to 
homogeneity are those from S. cerevisiae (13, 14) and Claviceps 
purpurea (11). The gene for the S. cerevisiae enzyme, IDI 1, was 
isolated from a genomic library by colony hybridization using 
oligonucleotide probes designed from the amino-terminal se­
quence of the protein. In yeast, IDI 1 is an essential single-copy 
gene (15).
Because of the unusual mechanism of action of IPP isomer­
ase and its widespread occurrence in nature, we wanted to 
isolate genes for the enzyme from a variety of organisms for 
comparative studies. Although the approach we used to isolate 
the yeast gene could be applied to other organisms, in some 
cases isomerase activity is very low and the protein difficult to 
purify (7, 14). An approach based on complementation of an 
IPP isomerase deficiency appeared to be more practical. Prior 
to our disruption of IDI 1 in S. cerevisiae (15), there were no 
reports of an IPP isomerase mutant suitable for complementa­
tion experiments. We decided to use the disrupted yeast strain 
FH1, a heterozygote for the idil::Leu2  disruption, for comple­
mentation experiments using the plasmid shuffle technique to
Flfi. 4. Plates from  test fo r com plementation o f d isrupted I D I  I 
by the truncated S .  c e r e v i s i a e  IPP isomerase gene contained in 
pFMHlO. P l a t e  A, YEPD master plate with restreaks of dissected asci. 
P l a t e  B ,  master plate replica plated to leu medium. P l a t e  C ,  master 
plate replica plated to ura , leu medium. P l a t e  D ,  mating type anal­
ysis showing spores able to mate by a patch of growth at cross-streaked 
intersections and thus likely to be haploid.
isolate conditional lethal mutations (24).
Haploid S. cerevisiae strain FH2-5b (MATa idi\::LEU 2  
pRS317://-)/1) was constructed by transformation of diploid 
strain FH1 followed by sporulation and isolation of the appro­
priate segregant. Transformation of FH2-5b with the S. pombe 
cDNA library followed by counterselection with «-AA gave 23 
survivors from a total of40,000 cotransformants. Four of the 23 
were cDNA clones for S. pombe /D/1. The remaining survivors 
were not fully characterized but could have arisen from muta­
tions resulting in inactivation of LYS2  or recombination events 
that separated IDI 1 from LYS2 in pFMHl. In any event, the 
frequency of false positives was only slightly greater than that 
for complementation by the cDNA for S. pombe IPP isomerase. 
This technique should be applicable for any heterologous li­
brary that can direct synthesis of an active IPP isomerase in 
yeast.
The orf for S. pombe IPP isomerase encoded a protein that 
lacked approximately 52 amino acids at the amino terminus of 
the S. cerevisiae enzyme. Recombinant S. pombe isomerase 
produced in E. coli was a stable protein whose specific activity 
was similar to that of the longer yeast enzyme. Although a 
truncated mutant of yeast isomerase lacking 45 amino acids at 
its amino terminus was less stable than wild-type enzyme, 
cell-free homogenates of E. coli clones had high levels of isomer­
ase activity, and FH1 transformants containing the gene for 
the truncated enzyme allowed complementation of disrupted 
IDI 1 following sporulation and dissection.
As shown in Fig. 5, alignment of the amino acid sequences for 
the two fungal isomerases reveals several regions of high sim­
ilarity. In particular, Cys139 in the S. cerevisiae enzyme and the 
corresponding residue, CysK7, in S. pombe isomerase are lo­
cated in identical sequences of 11 amino acids. Likewise, Glu2"' 
and Glu152 in the respective enzymes are found in regions 
containing 11 conserved amino acids. These cysteine and glu­
tamate residues are important components of the catalytic site 










A  P l a s m i d  S h u f f le  in  Y e a s t to  I s o la te  S . p o m b e  I D I 1 11303
ISOMPOMBE MSSQQEKK-----------------------------------------------------------------------  8
ISOMSCEREV MTADNNSMPHGAVSSYAKLVQNQTPEDILEEFPEIIPLQQRPNTRSSETS 50
ISOMHUMAN MMPEINT------------------------------------------------------------------------- 7
* • • . .
ISOMPOMBE ---------------- D YDEEQLRLMEEVCIWDENDVP LRYGTKKECHLMENINK 48
ISOMSCEREV NDESGETCFSGHDEEQIKLMNENCIVLDWDDNAIGAGTKKVCHLMENIEK 100
ISOMHUMAN -------------- NHLDKQQVQLLAEMCILIDENDNKIGAETKKNCHLNENIEK 48
* * * * ** * * *** *** *** *
Fig. 5. Sequence a lig n m e n t o f 
the th ree  eu ka ryo tic  IP P  isom er- 
ases: S. pom be  (ISOM POM BE), S. 
cerevisiae  (ISOMSCEREV), and hu ­
man (ISOMHUMAN). Identity is indi­
cated by *, and similarity is indicated by . . 
The active site residues identified in S. 
cerevisiae IPP isomerase, Cys139 and Glu207 
(see Ref. 16), are conserved in all three 
































ISOMPOMBE ---- YGFTPWFKLICEHFMFKWWQDVDHASKFQ-DTLIHRC- 227
ISOMSCEREV ---- YKFTPWFKIICENYLFNWWEQLDDLSEVENDRQIHRML 288
ISOMHUMAN SGEIKITPWFKIIAATFLFKWWDNLNHLNQFVDHEKIYR-M 228






I d e n t i ty :  94 ( 32.3%) S im i la r i ty :  79 ( 27.1%)
identical roles.
Recently Xuan et al. (19) isolated a hum an cDNA clone by 
differential hybridization of a hum an promyelocytic leukemia 
cell line with and without treatm ent with phorbol esters. Al­
though the encoded protein was not expressed and character­
ized biochemically, its amino acid sequence showed a high 
degree of similarity to S', cerevisiae IPP isomerase. In addition, 
the hum an protein also lacked the same amino-terminal region 
missing in the S. pombe enzyme. As shown in Fig. 5, the human 
and S. pombe proteins are of almost identical length and share 
the same highly conserved regions with the S. cerevisiae en­
zyme, including the identical stretches surrounding the active 
site cysteine and glutamate.
The S. cerevisiae strain FH2-5b was constructed to allow 
screening of the heterologous libraries for DNA encoding IPP 
isomerase by complementation through a selection/counter­
selection protocol. We used the approach to screen a S. pombe 
cDNA library in the presence of a-AA and isolated a clone for 
IPP isomerase. We anticipate th a t selection/counterselection 
with FH2-5b should be generally useful for isolating plasmids 
th a t can direct synthesis of functional IPP isomerase in 
genomic and cDNA libraries.
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